Showing results (101-110 of 258) with videos related to

Sort By:
Pageof 26
Proteomics|May 25, 2005
Proteome profile of human urine with two-dimensional liquid phase fractionationMonica Soldi, Cecilia Sarto, Cristina Valsecchi, et al.
Nucleic Acids Research|November 29, 2019
PRMT1-mediated methylation of the microprocessor-associated proteins regulates microRNA biogenesisValeria Spadotto, Roberto Giambruno, Enrico Massignani, et al.
Life (Basel, Switzerland)|March 28, 2026
Bright Light Therapy in Psychiatric Disorders: Mechanisms, Clinical Procedures and EvidenceSimone Pardossi, Letizia Bossini, Veronica Milani, et al.
Rivista Di Psichiatria|April 21, 2020
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazinaAndrea Fagiolini, Simone Bolognesi, Arianna Goracci, et al.
Frontiers in Immunology|May 28, 2025
HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapyValeria Spadotto, Chiara Ripamonti, Andrea Ghiroldi, et al.
Molecular & Cellular Proteomics : MCP|April 4, 2014
Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810Mara Colzani, Roberta Noberini, Mauro Romanenghi, et al.
EMBO Reports|March 7, 2018
Zc3h10 is a novel mitochondrial regulatorMatteo Audano, Silvia Pedretti, Gaia Cermenati, et al.
Epigenetics & Chromatin|July 15, 2025
H2A.X N-terminal acetylation is a newly identified NAA40-mediated modification that is responsive to UV irradiationAriel Klavaris, Costas Koufaris, Roberta Noberini, et al.
Frontiers in Immunology|August 21, 2025
Correction: HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapyValeria Spadotto, Chiara Ripamonti, Andrea Ghiroldi, et al.
Proteomics|October 18, 2006
Proteomic knowledge of human aquaporinsFulvio Magni, Cecilia Sarto, Davide Ticozzi, et al.
Pageof 26